Literature DB >> 28453921

Response to Real life Egyptian experience of efficacy / safety of Simeprevir\ Sofosbuvir in HCV genotype IV.

Rasha Eletreby1, Wafaa Elakel1, Maissa El Raziky1, Gamal Esmat1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28453921     DOI： 10.1111/liv.13319

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  1 in total

1.  Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes.

Authors:  Mohamed Darwish Ahmed Abd Alla; Reham M Dawood; Hassan Abd El-Hafeth Rashed; Galal Farrag; Islam Abdelmawla Emran Ammar; Mohamed Mahmoud Abdel-Halim Mahmoud; Ghada M Salum; Ahmed Mohamed Abdulhamid Altanbouly; Mai A El Meguid; Mostafa K El Awady
Journal:  Arch Virol       Date:  2021-02-03       Impact factor: 2.574
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.